Endocervical Cancer clinical trials at UCLA
1 in progress, 0 open to eligible people
Showing trials for
NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies
Sorry, in progress, not accepting new patients
Study of NGM707 as Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies
Santa Monica', California and other locations
Our lead scientists for Endocervical Cancer research studies include Joel Hecht.
Last updated: